Pulmonary Hypertension (PH) Completed Phase 3 Trials for Riociguat (DB08931)

Also known as: Hypertension, Pulmonary / Pulmonary; Hypertension / Pulmonary hypertension / Hypertension Pulmonary / Pulmonary hypertensions / Pulmonary hypertension NOS

IndicationStatusPhase
DBCOND0051788 (Pulmonary Hypertension (PH))Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00863681BAY63-2521:Long-term Extension Study in Patients With Pulmonary Arterial HypertensionTreatment
NCT02007629Riociguat Clinical Effects Studied in Patients With Insufficient Treatment Response to Phosphodiesterase-5 InhibitorTreatment
NCT00910429BAY63-2521 - Long-term Extension Study in Patients With Chronic Thromboembolic Pulmonary HypertensionTreatment
NCT00810693A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With Pulmonary Arterial Hypertension (PAH)Treatment
NCT00855465A Study to Evaluate Efficacy and Safety of Oral BAY63-2521 in Patients With CTEPH.Treatment